SeedtoB Capital

SeedToB Capital is a venture capital firm based in Suwanee, Georgia, founded in 2021. The firm specializes in healthcare technology, with a particular emphasis on artificial intelligence initiatives within the healthcare sector. Despite significant investments in AI applications, many do not reach their full potential, often remaining in pilot or early adopter stages. SeedToB Capital aims to address this challenge by guiding entrepreneurs through the complexities of the healthcare landscape, helping them find the most efficient path to secure Series B funding. The firm is led by seasoned entrepreneurs who previously founded Jvion, which became the largest clinical AI company in the nation before being sold in a significant cash transaction.

Shantanu Nigam

Co-Founder and Managing Partner

Ritesh Sharma

Managing Partner

17 past transactions

OncoLens

Series B in 2024
OncoLens develops a HIPAA-compliant platform that streamlines cancer treatment planning. It integrates disparate data sets, facilitates multidisciplinary discussions among oncology care teams, and automates accreditation processes to enable more informed clinical decisions.

Shimmer

Seed Round in 2024
Shimmer provides a platform for 1:1 remote ADHD coaching. Our platform matches users to an ADHD coach who helps guide them towards identifying and meeting goals, maintaining a positive approach to change, and improving productivity while providing a source of accountability.

Feel Therapeutics

Venture Round in 2024
Feel Therapeutics is a digital health company specializing in precision medicine for mental health. It develops physiological and digital biomarkers using advanced computer science methods, leveraging wearable devices to collect and analyze biometric data.

Canid

Seed Round in 2023
Canid is a healthcare technology company that focuses on pediatric vaccination workflows. It provides a healthcare dashboard and process tool to simplify vaccination record management, automate vaccine workflow, and oversee vaccine inventory. The platform includes a scanning system that eliminates manual data entry by capturing vaccine information and uploading it to state immunization registries, reducing administrative tasks for pediatric practitioners. It also offers administrative consulting and helps secure vaccine margins, supporting efficient practice operations for clinicians while giving state officials clearer oversight of vaccination programs.

AngelEye Health

Series B in 2022
AngelEye Health is a developer of a tele-engagement platform designed to integrate parents into the care team during their child's stay in neonatal intensive care units (NICUs) and pediatric units. The company offers a comprehensive, HIPAA-compliant solution that includes bedside cameras, patient communication tools, feeding management systems, and targeted educational resources. These services enhance care team workflows and provide families with improved access to their child's treatment plans and progress through any connected device. By fostering meaningful care experiences, AngelEye Health aims to improve family satisfaction, enhance care delivery efficiency, and ultimately elevate the quality of care for patients.

Biotia

Series A in 2022
Biotia, Inc. is a health technology company based in New York, founded in 2016. It specializes in developing software and laboratory technologies that leverage next-generation DNA sequencing and artificial intelligence to enhance infectious disease discovery and management. By providing tailored microbial surveillance, Biotia's innovative solutions enable clinicians and researchers to identify and mitigate pathogens effectively, thereby reducing hospital-acquired infections and improving patient outcomes. The company's technology empowers healthcare professionals to guide treatment decisions proactively, ultimately aiming to prevent illnesses before they occur.

STRIVE

Series A in 2022
STRIVE provides a platform that uses sensors in compression shorts to gather muscle movement data via surface electromyography (sEMG) and accelerometers. This data helps athletes, military personnel, and industrial workers track muscle activity, monitor fatigue, prevent injuries, and enhance performance.

Mployer Advisor

Seed Round in 2022
Mployer Advisor is an independent platform designed for employers to research, review, and evaluate insurance brokers.

curie ai

Seed Round in 2022
Curie AI is a tech-enabled respiratory care company providing virtual personalized disease management through proprietary AI that passively detects symptoms. This approach results in high adherence, reduction in adverse events, cost savings, and improving overall quality of life for people with chronic respiratory conditions

Heading Health

Seed Round in 2022
Heading Health is a technology-driven platform enhancing access to affordable mental health care. It offers personalized treatment solutions, combining evidence-based therapeutics with advanced technologies like transcranial magnetic stimulation, telepsychiatry, and intramuscular ketamine.

Zeit Medical

Seed Round in 2021
Zeit Medical is a company focused on advancing the treatment of neurological injuries through innovative technology. Founded in 2019 by Urs Naber and Orestis Vardoulis, the company has developed a specialized headband that continuously monitors the electrical activity of the brain. This device integrates smoothly with existing electroencephalogram (EEG) systems and automates the pre-screening process, facilitating the annotation of extensive datasets. By identifying signature patterns in EEG readings, Zeit Medical enables physicians to diagnose and treat neurological conditions with greater precision, particularly in detecting the onset of strokes.

GritWell

Seed Round in 2021
GritWell Ltd is a digital health platform that specializes in addressing chronic health conditions through a holistic approach. Founded in 2018 and based in San Francisco, the company connects patients with a variety of health professionals, including nutritionists, health coaches, and naturopathic doctors. GritWell's platform facilitates secure video consultations, direct messaging, and online scheduling, allowing for personalized treatment plans and credible advice tailored to individual needs. By focusing on root cause treatment rather than mere symptom management, GritWell employs clinically validated symptom assessments to guide patients toward appropriate care while integrating natural treatment options. This innovative approach aims to improve health outcomes by enabling patients to find practitioners who can address the underlying issues of their chronic symptoms, such as insomnia, migraines, and anxiety.

Moonlight Therapeutics

Series A in 2021
Moonlight Therapeutics is a biotechnology company developing targeted immunotherapy treatments for food allergies. It uses its proprietary platform, Targeted Allergen Specific Immunotherapy (TASIS), to deliver allergens directly to immune cells in the skin, aiming to reduce allergic reactions and improve patients' quality of life.

Feel Therapeutics

Seed Round in 2021
Feel Therapeutics is a digital health company specializing in precision medicine for mental health. It develops physiological and digital biomarkers using advanced computer science methods, leveraging wearable devices to collect and analyze biometric data.

OncoLens

Series A in 2021
OncoLens develops a HIPAA-compliant platform that streamlines cancer treatment planning. It integrates disparate data sets, facilitates multidisciplinary discussions among oncology care teams, and automates accreditation processes to enable more informed clinical decisions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.